AZoLifeSciences on MSN
Kinetic traps explain differences in GPCR drug efficacy
G-protein coupled receptors (GPCRs) are proteins triggered by ligands (protein-binding chemicals) from outside cells to transmit signals inside the cell.
Researchers discover possible weakness in deadly hospital superbug C. auris that could lead to new treatments for the ...
Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...
When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...
Despite limited uptake, weight-loss drugs have topped drug sales in India by value — marking a shift in how people perceive ...
Despite limited uptake, weight-loss drugs have topped drug sales in India by value — marking a shift in how people perceive ...
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based Histologic ...
A deadly, drug-resistant fungus, Candida auris, is spreading globally, with 7,000 US cases in 2025. Researchers warn of ...
IFLScience on MSN
Experimental Alzheimer’s drug could have the power to halt disease before symptoms even start
A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear.
In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...
For most of their lives, the two women have stayed tucked away indoors, sidelined by a rare blood disorder that makes the ...
Biosimilar development costs could plummet from $100 million to $5 million, enabling smaller companies to enter the market ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果